(Q41276467)

29 September 2017

1 reference

title

The potential biological and clinical significance of the soluble tumor necrosis factor receptors (English)

1 reference

29 September 2017

Aderka D

1 reference

29 September 2017

publication date

1 October 1996

1 reference

Cytokine and Growth Factor Reviews

29 September 2017

published in

1 reference

29 September 2017

1 reference

29 September 2017

1 reference

29 September 2017

page(s)

231-240

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

29 September 2017

1 reference

7 January 2021

Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Bioactive human recombinant tumor necrosis factor-alpha: an unstable dimer?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Shedding from the cell surface of normal and cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Tumor necrosis factor expression in human epithelial tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

In situ detection of tumour necrosis factor in human ovarian cancer specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Paradoxical effects of tumour necrosis factor in experimental ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Cells secreting tumour necrosis factor show enhanced metastasis in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Patterns of proinflammatory cytokines and inhibitors during typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Soluble receptors for tumor necrosis factor as markers of disease activity in visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Soluble tumor necrosis factor receptors in human inflammatory synovial fluids

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Assessment of a possible imbalance between tumor necrosis factor (TNF) and soluble TNF receptor forms in tuberculous infection of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Elevated Levels of Soluble Interleukin 2 Receptor and Tumor Necrosis Factor in Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Serum-soluble receptors for tumor necrosis factor-alpha and interleukin-2, and neopterin in acute rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Trauma causes early release of soluble receptors for tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Cytokines in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Tumor necrosis factor and cardiac function.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2896%2900026-3

7 January 2021

10.1016/S1359-6101(96)00026-3

Identifiers

DOI

1 reference

release_7jmgu3xb4zhlfm77pkpunmdbgq

29 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7jmgu3xb4zhlfm77pkpunmdbgq

24 November 2022

mapped directly with Wikidata item

1 reference